Susan Lintonsmith
First SEC filing: July 1, 2026 · Latest: July 1, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2026 | STKS | A | 19,531 | · | · | 153,613 Direct | +14.57% | Acquired | (price as of 2026-10-02) |
| June 30, 2026 | STKS | A | 15,547 | · | · | 134,082 Direct | +13.12% | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | STKS | A | 17,556 | · | · | 118,535 Direct | +17.39% | Acquired | (price as of 2026-10-02) |
| March 16, 2026 | RGS | A | 12,125 | · | · | 19,074 Direct | +174.49% | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2025 | STKS | A | 17,857 | · | · | 100,979 Direct | +21.48% | Acquired | (price as of 2026-10-02) |
| Dec. 4, 2025 | RGS | A | 1,470 | · | · | 6,949 Direct | +26.83% | Acquired | (price as of 2026-10-02) |
| Nov. 14, 2025 | RGS | A | 2,727 | · | · | 5,479 Direct | +99.09% | Acquired | (price as of 2026-10-02) |
| Sept. 30, 2025 | STKS | A | 10,557 | · | · | 83,122 Direct | +14.55% | Acquired | (price as of 2026-10-02) |
| June 30, 2025 | STKS | A | 6,481 | · | · | 72,565 Direct | +9.81% | Acquired | (price as of 2026-10-02) |
| March 31, 2025 | STKS | A | 8,779 | · | · | 66,084 Direct | +15.32% | Acquired | (price as of 2026-10-02) |
| Jan. 15, 2025 | RGS | A | 2,752 | · | · | 2,752 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2024 | STKS | A | 9,051 | · | · | 57,305 Direct | +18.76% | Acquired | (price as of 2026-10-02) |
| Sept. 30, 2024 | STKS | A | 7,133 | $3.68 | $26,249 | 48,254 Direct | +17.35% | Acquired | -57.6% (price as of 2026-10-02) |
| June 28, 2024 | STKS | A | 6,176 | $4.25 | $26,248 | 41,121 Direct | +17.67% | Acquired | -63.3% (price as of 2026-10-02) |
| April 2, 2024 | STKS | A | 4,581 | $5.73 | $26,249 | 34,945 Direct | +15.09% | Acquired | -72.8% (price as of 2026-10-02) |
| Dec. 29, 2023 | STKS | A | 4,289 | $6.12 | $26,249 | 30,364 Direct | +16.45% | Acquired | -74.5% (price as of 2026-10-02) |
| Sept. 29, 2023 | STKS | A | 4,773 | $5.50 | $26,252 | 26,075 Direct | +22.41% | Acquired | -71.6% (price as of 2026-10-02) |
| June 30, 2023 | STKS | A | 3,586 | $7.32 | $26,250 | 21,302 Direct | +20.24% | Acquired | -78.7% (price as of 2026-10-02) |
| March 31, 2023 | STKS | A | 3,241 | $8.10 | $26,252 | 17,716 Direct | +22.39% | Acquired | -80.7% (price as of 2026-10-02) |
| Dec. 30, 2022 | STKS | A | 2,232 | $6.30 | $14,062 | 14,475 Direct | +18.23% | Acquired | -75.2% (price as of 2026-10-02) |
| Sept. 30, 2022 | STKS | A | 2,117 | $6.64 | $14,057 | 12,243 Direct | +20.91% | Acquired | -76.5% (price as of 2026-10-02) |
| June 29, 2022 | STKS | A | 1,915 | $7.34 | $14,056 | 10,126 Direct | +23.32% | Acquired | -78.7% (price as of 2026-10-02) |
| March 30, 2022 | STKS | A | 1,343 | $10.47 | $14,061 | 8,211 Direct | +19.55% | Acquired | -85.1% (price as of 2026-10-02) |
| Dec. 29, 2021 | STKS | A | 845 | $12.36 | $10,444 | 6,868 Direct | +14.03% | Acquired | -87.4% (price as of 2026-10-02) |
| Sept. 30, 2021 | STKS | A | 1,169 | · | · | 6,023 Direct | +24.08% | Acquired | (price as of 2026-10-02) |
| Sept. 13, 2021 | STKS | A | 4,854 | · | · | 4,854 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2026 | · | · | $291,000 | · | $284,413 | · | $347 | $762,427 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.